Erratum to: Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer
更正：艾立布林甲磺酸盐作为局部复发或转移性人表皮生长因子受体2阴性乳腺癌一线治疗的II期研究
期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-014-3245-7
Twelves, Chris; Cortes, Javier; Vahdat, Linda; Olivo, Martin; He, Yi; Kaufman, Peter A; Awada, Ahmad; Filipović, Aleksandra; Lombardo, Ylenia; Faronato, Monica; Abrahams, Joel; Aboagye, Eric; Nguyen, Quang-De; d’Aqua, Barbara Borda; Ridley, Anne; Green, Andrew; Rahka, Emad; Ellis, Ian; Recchi, Chiara; Przulj, Natasa; Sarajlić, Anida; Alattia, Jean-Rene; Fraering, Patrick; Deonarain, Mahendra; Coombes, R Charles; McIntyre, Kristi; O’Shaughnessy, Joyce; Schwartzberg, Lee; Glück, Stefan; Berrak, Erhan; Song, James X; Cox, David; Vahdat, Linda T
